Namibia is hailed as one of the front-runners in AIDS treatment rollout, yet there is growing fear that this success might be short-lived if services do not reach rural communities. The government has increased the number of sites offering antiretroviral (ARV) treatment from seven three years ago to 34 at present, but most of the clinics were set up in the densely populated northern regions, far from people living on farms and in rural villages.
Equity and HIV/AIDS
Currently South Africa does not have national HIV incidence data based on laboratory testing of blood specimens. The 2005 South African national HIV household survey was analysed to generate national incidence estimates stratified by age, sex, race, province and locality type, to compare the HIV incidence and HIV prevalence profiles by sex, and to examine the relationship between HIV prevalence, HIV incidence and associated risk factors. HIV incidence in the study population aged 2 years and older was 1.4% per year, with 571 000 new HIV infections estimated for 2005. An HIV incidence rate of 2.4% was recorded for the age group 15-49 years. The incidence of HIV among females peaked in the 20-29-year age group at 5.6%, more than six times the incidence found in 20-29-year-old males (0.9%). Among youth aged 15-24 years, females account for 90% of the recent HIV infections. Non-condom use among youth, current pregnancy and widowhood were the socio-behavioural factors associated with the highest HIV incidence rates. The HIV incidence estimates reflect the underlying transmission dynamics that are currently at work in South Africa. The findings suggest that the current prevention campaigns are not having the desired impact, particularly among young women.
This review of the HIV and AIDS national strategic plan (NSP) since the NSP's inception in 2007, reports that condom use has almost doubled, treatment coverage among adults living with HIV has almost tripled, and prevention of mother-to-child HIV transmission (PMTCT) services among HIV-positive pregnant women has reached 76%. In contrast, the uptake of dual ARV therapy PMTCT has been problematic, and there are major shortcomings in monitoring and evaluation (M&E) that could leave decision-makers operating in a vacuum, the report warns. It notes that while provinces had adopted the dual therapy regimen and were training health workers to administer it, some districts were still using the outdated single dose of Nevirapine because funding to buy the ARVs for dual therapy was problematic. It also highlights a dearth of data on babies born HIV-positive, but quotes department of health estimates showing that almost 40% of infants exposed to HIV were put at risk of contracting the virus by incomplete provision of PMTCT services. Problems with monitoring and evaluation were also highlighted, with inadequate data on mothers, babies and HIV-positive patients awaiting treatment. The report suggests that measuring South Africa's success against numerous goals and objectives set by the NSP may be logistically and bureaucratically challenging. Despite a wealth of information on HIV and AIDS that is collected to fulfill government reporting requirements, the uneven quality, scope and availability of the data has presented considerable challenges to those trying to implement evidence-based HIV interventions.
This National Strategic Plan (NSP) has four strategic objectives, which will form the basis of the HIV, STI and TB response: address social and structural barriers to HIV, sexually transmitted infection (STI) and TB prevention, care and impact; prevent new HIV, STI and TB infections; sustain health and wellness; and increase protection of human rights and improve access to justice. The NSP is driven by a long-term 20-year vision for the country with respect to the HIV and TB epidemics, adapting the Three Zeros advocated by UNAIDS, and additional one for discrimination: zero new HIV and TB infections; zero new infections due to vertical transmission (mother-to-child); zero preventable deaths associated with HIV and TB; and zero discrimination associated with HIV and TB. In line with this 20-year vision, the NSP has the following broad goals: reduce new HIV infections by at least 50% using combination prevention approaches; initiate at least 80% of eligible patients on antiretroviral treatment (ART), with 70% alive and on treatment five years after initiation; reduce the number of new TB infections as well as deaths from TB by 50%; ensure an enabling and accessible legal framework that protects and promotes human rights to support implementation of the NSP; and reduce self-reported stigma related to HIV and TB by at least 50%.
This paper explored the extent to which public sector roll-out has met the estimated need for paediatric treatment in a rural South African setting. Local facility and population-based data were used to compare the number of HIV infected children accessing HAART before 2008, with estimates of those in need of treatment from a deterministic modeling approach. The impact of programmatic improvements on estimated numbers of children in need of treatment was assessed in sensitivity analyses. It found that, if PMTCT uptake were extended to reach 100% coverage, the annual number of infected infants could be reduced by 49.2%. Despite progress in delivering decentralised HIV services to a rural sub-district in South Africa, substantial unmet need for treatment remains. In a local setting, very few children were initiated on treatment under one year of age and steps have now been taken to successfully improve early diagnosis and referral of infected infants.
This study explored how women’s and men’s gendered experiences from childhood to old age have shaped their vulnerability in relation to HIV both in terms of their individual risk of HIV and their access to and experiences of HIV services. It was a small scale-scale study conducted in urban and rural sites in Uganda between October 2011 and March 2012. The study used qualitative methods: in-depth interviews (with 31 participants) and focus group discussions (FGDs) with older women (2) and men (2) in urban and rural sites and 7 key informant interviews (KIIs) with stakeholders from government and non-government agencies working on HIV issues. Women’s position, the cultural management of sex and gender and contextual stigma related to HIV and to old age inter-relate to produce particular areas of vulnerability to the HIV epidemic among older women and men. Women report the compounding factor of gender-based violence marking many of their sexual relationships throughout their lives, including in older age. Both women and men report extremely fragile livelihoods in their old age. Older people are exposed to HIV through multiple and intersecting drivers of risk and represent an often neglected population within health systems. The author argues that research and interventions need to go beyond only conceptualising older people as ‘carers’ to better address their gendered vulnerabilities to HIV in relation to all aspects of policy and programming.
Aids in Africa is a symptom of an unjust global order, argues the author of this article. Mass poverty leaves people with no option other than labour migration and transactional sex, which he identifies as the key drivers of HIV transmission in southern Africa. Old approaches to rolling back AIDS don’t work any longer – what is needed is a new, more systematic approach in which poor African countries are released from structural adjustment programmes so they can rebuild their economies using tariffs, subsidies, state spending and low interest rates – the very policies that rich countries use. The author also calls for the cancellation of odious debts so African countries can spend money on health services instead of interest payments. Furthermore, governments need to amend TRIPS to decommoditise life-saving drugs and amend the World Trade Organisation’s (WTO) Agreement on Agriculture to ban the dumping of subsidised farm products in Africa and elsewhere. This means reforming the World Bank, the International Monetary Fund and the WTO, where voting power is monopolised by rich nations and special interests. The World Bank and the Gates Foundation – the biggest funders of AIDS prevention – cannot be entrusted with these tasks, as they have clear interests in the very policies (debt service, structural adjustment and patent laws) that have created the problem in the first place.
AIDS Healthcare Foundation endorsed President Bush's efforts to support cost-effective and sustainable programs that provide life-saving Anti-retroviral HIV and AIDS treatment and care globally. The Presidential Emergency Plan for AIDS Relief (PEPFAR) is a $15 billion dollar, five-year global AIDS treatment plan the President first proposed in 2003.
A campaign launched recently seeks to mobilise political will and financial resources to overcome the bottle-necks that hinder services for children who have HIV and to prevent HIV infection in children. The Campaign to End Paediatric HIV/AIDS (CEPA) will initially launch in six African countries: Kenya, Uganda, Tanzania, Nigeria, Zambia and Mozambique. Its chairperson, Graca Machel, said CEPA seeks to address the bottlenecks encountered in delivering diagnostic, treatment and care services in these countries. ‘In South Africa alone, 280,000 children are said to be having HIV. It is estimated that 1.8 million of the world’s HIV-positive children are in Africa,’ she said. One of CEPA’s goals is to prevent HIV infection from parent to child. Openly HIV-positive TV host and head of Nigeria’s Positive Action for Treatment Access Movement (PATAM), Rolake Odetoyinbo, knows that that can be achieved. The campaign, formed by the United States’s Global AIDS Alliance, has set itself a bold target to increase prevention of mother-to-child HIV transmission and paediatric treatment services from the current average of 30–40% to 80% in three years in the countries it’s working in. A total budget of US$6 million has been set aside to benefit the six countries that are currently being targeted.
Children living with HIV in Uganda have been given greater access to treatment with a new paediatric HIV care centre opened at the main referral hospital in the capital, Kampala. More than 20,000 children are infected with HIV every year, and 50 percent of them die before their second birthday. There is still inadequate access to paediatric HIV care and treatment services in Uganda –out of the 330 active antiretroviral therapy centres in Uganda, only 110 are able to provide paediatric HIV care services, and most of these are located in urban centres. The centre at Mulago Hospital is the first to provide a comprehensive package of HIV care and treatment services for children and adolescents infected or exposed to HIV, including testing, treatment, counselling of children and their families, and training healthcare professionals in the management of paediatric HIV.
